Human umbilical cord-derived mesenchymal stem cell therapy (Baolai Biotech)

人脐带间充质干细胞（葆来生物）

Report date: 2025/10/09 15:04:27

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Baolai Biotech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCerebral Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Baolai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCerebral Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A